Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Feb 22, 2010
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All liver transplant patients in our center between May 2005 and April 2008 were potentially eligible for enrollment
- Exclusion Criteria:
- • Age less than 18 years
- • Treatment with UDCA within one month before operation
- • Inability to provide written informed consent prior to study entry
- • Non-liver organ(s) failure prior to entry
About Shanghai Jiao Tong University School Of Medicine
Shanghai Jiao Tong University School of Medicine is a leading academic institution in China, renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, the school leverages its extensive expertise in biomedical sciences and innovative healthcare solutions to conduct rigorous clinical studies aimed at improving patient outcomes. With a focus on collaboration and translational research, the institution fosters partnerships with healthcare providers, industry leaders, and regulatory bodies to ensure the highest standards of scientific integrity and ethical conduct in clinical trials. Through its research initiatives, Shanghai Jiao Tong University School of Medicine strives to contribute significantly to the global medical community and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Zhi-Hai Peng, MD
Study Chair
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials